Caption Management’s Boston Scientific BSX Stock Holding History

Caption Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$55.1M	Buy	1,290,600 +415,600	+47%	+$22.6M	0.26%	78
2026 Q1	$54.9M	Buy	875,000 +459,200	+110%	+$36.7M	0.32%	64
2025 Q4	$39.6M	Sell	415,800 -62,900	-13%	-$6.17M	0.27%	82
2025 Q3	$46.7M	Buy	478,700 +442,700	+1,230%	+$45.8M	0.36%	50
2025 Q2	$3.87M	Buy	+36,000	New	+$3.64M	0.04%	478
2025 Q1	–	Sell	-35,000	Closed	-$3.13M	–	1553
2024 Q4	$3.13M	Buy	+35,000	New	+$3.08M	0.03%	537
2024 Q3	–	Sell	-65,000	Closed	-$5.01M	–	1292
2024 Q2	$5.01M	Buy	+65,000	New	+$4.76M	0.08%	257
2023 Q2	–	Sell	-125,000	Closed	-$6.25M	–	1118
2023 Q1	$6.25M	Buy	+125,000	New	+$5.89M	0.12%	195
2022 Q2	–	Sell	-200,000	Closed	-$8.86M	–	1479
2022 Q1	$8.86M	Buy	+200,000	New	+$8.67M	0.11%	257
2020 Q1	–	Sell	-156,300	Closed	-$7.07M	–	870
2019 Q4	$7.07M	Buy	+156,300	New	+$6.54M	0.24%	103
2019 Q1	–	Sell	-70,000	Closed	-$2.47M	–	577
2018 Q4	$2.47M	Buy	70,000 +30,000	+75%	+$1.09M	0.2%	152
2018 Q3	$1.54M	Buy	+40,000	New	+$1.4M	0.08%	277

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Caption Management's BSX Position: Q2 2026 in Review

Caption Management reduced its Boston Scientific (BSX) stake by 17% in Q2 2026, selling an estimated $3.39M and leaving 312,050 shares worth $13.3M. The position accounts for 0.06% of the portfolio, ranked #322.

Caption Management first reported a position in BSX in Q4 2018 and has held it in 11 quarters since. The position peaked at $23.5M in Q1 2026. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Caption Management held 312,050 shares of Boston Scientific worth $13.3M as of Q2 2026.
Caption Management sold 62,350 Boston Scientific shares in Q2 2026, an estimated $3.39M.
Boston Scientific made up 0.06% of Caption Management's portfolio in Q2 2026, its #322 holding.
Caption Management first reported a position in Boston Scientific in Q4 2018 and has held it in 11 quarters since.
Caption Management's Boston Scientific position peaked at $23.5M in Q1 2026.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.